Hot Pursuit     23-Feb-23
Biocon Ltd drops for fifth straight session
Biocon Ltd is quoting at Rs 219.75, down 1.12% on the day as on 13:19 IST on the NSE. The stock tumbled 41.27% in last one year as compared to a 8.17% rally in NIFTY and a 4.33% fall in the Nifty Metal index.

Biocon Ltd is down for a fifth straight session today. The stock is quoting at Rs 219.75, down 1.12% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.12% on the day, quoting at 17576.2. The Sensex is at 59835.52, up 0.15%.Biocon Ltd has eased around 10.73% in last one month.Meanwhile, Nifty Metal index of which Biocon Ltd is a constituent, has eased around 5.04% in last one month and is currently quoting at 11991.85, down 0.28% on the day. The volume in the stock stood at 26.16 lakh shares today, compared to the daily average of 29.96 lakh shares in last one month.

The benchmark February futures contract for the stock is quoting at Rs 219.3, down 1.48% on the day. Biocon Ltd tumbled 41.27% in last one year as compared to a 8.17% rally in NIFTY and a 4.33% fall in the Nifty Metal index.

The PE of the stock is 152.16 based on TTM earnings ending December 22.

Previous News
  Biocon Biologics receives GMP certifications for its Indian and Malaysian manufacturing units
 ( Corporate News - 24-Jun-24   09:01 )
  Biocon arm joins hands with Civica to expand diabetic drug in US
 ( Hot Pursuit - 07-Mar-25   13:43 )
  Biocon arm gets USFDA nod for chronic heart failure drug
 ( Hot Pursuit - 02-Sep-24   08:59 )
  Biocon gets US FDA nod for fungal infection drug
 ( Hot Pursuit - 04-Jun-24   11:18 )
  Biocon, Zentiva get approval for diabetes tratement drug Liraglutide for EU region
 ( Hot Pursuit - 24-Dec-24   09:37 )
  Biocon jumps as Bengaluru unit gets VAI status from USFDA
 ( Hot Pursuit - 24-Dec-24   15:42 )
  Biocon's new monoclonal antibodies facility in India get manufacturing approval from EMA
 ( Hot Pursuit - 24-Jun-24   09:34 )
  Biocon
 ( Results - Analysis 13-Nov-23   12:15 )
  Biocon and Zentiva receive Decentralized Procedure approval for Liraglutide
 ( Corporate News - 24-Dec-24   09:27 )
  Biocon Biologics completes integration of Viatris' biosimilars business in 31 European countries
 ( Corporate News - 30-Nov-23   16:49 )
  Biocon Biologics divests its non-crore branded formulations biz in India
 ( Corporate News - 10-Nov-23   12:06 )
Other Stories
  Prism Johnson appoints key senior management personnels
  24-Mar-25   16:02
  GHV Infra Projects hits the roof after bagging Rs 191-cr order
  24-Mar-25   15:20
  Jyoti Structures Ltd leads losers in 'A' group
  24-Mar-25   15:00
  Rudra Gas hits the roof after bagging LoA from BPCL for Rs 33-cr project
  24-Mar-25   14:59
  Khandwala Securities Ltd leads losers in 'B' group
  24-Mar-25   14:45
  L&T gains as arm ink MoU with John Cockerill to explore various technologies
  24-Mar-25   14:37
  Volumes spurt at Finolex Industries Ltd counter
  24-Mar-25   14:30
  India Ratings affirms Sheela Foam's LT rating at 'AA' with 'stable' outlook
  24-Mar-25   13:43
  Diamond Power Infra hits the roof after bagging LoI from Adani Green for Rs 215 crore project
  24-Mar-25   13:11
  Kotak Mahindra Bank Ltd spurts 4.56%, rises for third straight session
  24-Mar-25   13:05
Back Top